158 related items for PubMed ID: 31295009
1. The Efficacy and Safety of Xinmailong Injection in Patients with Chronic Heart Failure: A Multicenter Randomized Double-Blind Placebo-Controlled Trial.
Xue J, Xu Y, Deng Y, Li F, Liu F, Liu L, Wang X, Wang J, Wang X.
J Altern Complement Med; 2019 Aug; 25(8):856-860. PubMed ID: 31295009
[Abstract] [Full Text] [Related]
2. Safety and efficacy of Qishen granules in patients with chronic heart failure: study protocol for a randomized controlled trial.
Wang J, Shi J, Wei J, Wang J, Gao K, Li X, Chen J, Li S, Zhao H, Wang W.
Trials; 2017 Oct 10; 18(1):468. PubMed ID: 29017565
[Abstract] [Full Text] [Related]
3. [Treatment of Chronic Heart Failure Patients with Qi-Yang Deficiency and Blood Stasis Resistance Syndrome by Xnmallong Injection: a Multi-center Randomized Control Study].
Xue JG, Wang XL, Xu Y, Li FC, Liu L, Wang X, Wang JZ, Liu F.
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Jul 10; 35(7):796-800. PubMed ID: 26380441
[Abstract] [Full Text] [Related]
4. A multicenter, randomized, double-blind, parallel-group, placebo-controlled study of the effects of qili qiangxin capsules in patients with chronic heart failure.
Li X, Zhang J, Huang J, Ma A, Yang J, Li W, Wu Z, Yao C, Zhang Y, Yao W, Zhang B, Gao R, Efficacy and Safety of Qili Qiangxin Capsules for Chronic Heart Failure Study Group.
J Am Coll Cardiol; 2013 Sep 17; 62(12):1065-1072. PubMed ID: 23747768
[Abstract] [Full Text] [Related]
5. A randomized, double-blind, multicenter, placebo-controlled clinical study on the efficacy and safety of Shenmai injection in patients with chronic heart failure.
Xian S, Yang Z, Lee J, Jiang Z, Ye X, Luo L, Jin L, Yang T, Ye S, Lu D.
J Ethnopharmacol; 2016 Jun 20; 186():136-142. PubMed ID: 27045864
[Abstract] [Full Text] [Related]
6. Clinical assessment of Shenfu injection loading in the treatment of patients with exacerbation of chronic heart failure due to coronary heart disease: study protocol for a randomized controlled trial.
Liu C, Hou Y, Wang X, Zhao Z, Liu Z, Zhai J, Mao J, Shang H.
Trials; 2015 May 21; 16():222. PubMed ID: 25994188
[Abstract] [Full Text] [Related]
7. Use of gated myocardial perfusion imaging to assess clinical value of xinmailong injection in chronic congestive heart failure.
Liu Y, Wang Z, Xiao W, Li Y.
J Tradit Chin Med; 2014 Oct 21; 34(5):555-9. PubMed ID: 25417405
[Abstract] [Full Text] [Related]
8. A multi-center, randomized, double-blind, placebo-parallel controlled trial for the efficacy and safety of shenfuqiangxin pills in the treatment of chronic heart failure (Heart-Kidney yang deficiency syndrome).
Guo L, Yuan H, Zhang D, Zhang J, Hua Q, Ma X, Chen K.
Medicine (Baltimore); 2020 May 22; 99(21):e20271. PubMed ID: 32481305
[Abstract] [Full Text] [Related]
9. [Network Meta-analysis of different Chinese medicine injections combined with conventional western medicine in treatment of acute heart failure].
Wang W, Kong FT, Li R, Zhao XK, Li YD, Liu K.
Zhongguo Zhong Yao Za Zhi; 2024 Jan 22; 49(1):251-267. PubMed ID: 38403358
[Abstract] [Full Text] [Related]
10. Effect of Carvedilol on Serum Heart-type Fatty Acid-binding Protein, Brain Natriuretic Peptide, and Cardiac Function in Patients With Chronic Heart Failure.
Sun YP, Wei CP, Ma SC, Zhang YF, Qiao LY, Li DH, Shan RB.
J Cardiovasc Pharmacol; 2015 May 22; 65(5):480-4. PubMed ID: 25945865
[Abstract] [Full Text] [Related]
11. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
Jorsal A, Kistorp C, Holmager P, Tougaard RS, Nielsen R, Hänselmann A, Nilsson B, Møller JE, Hjort J, Rasmussen J, Boesgaard TW, Schou M, Videbaek L, Gustafsson I, Flyvbjerg A, Wiggers H, Tarnow L.
Eur J Heart Fail; 2017 Jan 22; 19(1):69-77. PubMed ID: 27790809
[Abstract] [Full Text] [Related]
12. Clinical efficacy of water extract of stem bark of Terminalia arjuna (Roxb. ex DC.) Wight & Arn. in patients of chronic heart failure: a double-blind, randomized controlled trial.
Maulik SK, Wilson V, Seth S, Bhargava B, Dua P, Ramakrishnan S, Katiyar CK.
Phytomedicine; 2016 Oct 15; 23(11):1211-9. PubMed ID: 26988798
[Abstract] [Full Text] [Related]
13. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
Feola M, Aspromonte N, Milani L, Bobbio M, Bardellotto S, Barro S, Giovinazzo P, Noventa F, Valle R.
J Card Fail; 2008 Jun 15; 14(5):420-5. PubMed ID: 18514935
[Abstract] [Full Text] [Related]
14. Effects of Traditional Chinese Medicine Shensong Yangxin Capsules on Heart Rhythm and Function in Congestive Heart Failure Patients with Frequent Ventricular Premature Complexes: A Randomized, Double-blind, Multicenter Clinical Trial.
Wang X, Hu D, Dang S, Huang H, Huang CX, Yuan MJ, Tang YH, Zheng QS, Yin F, Zhang S, Zhang BL, Gao RL, Efficacy and Safety of Shensong Yangxin Capsules for Frequent VPCs in Congestive Heart Failure Study Group.
Chin Med J (Engl); 2017 Jul 20; 130(14):1639-1647. PubMed ID: 28685712
[Abstract] [Full Text] [Related]
15. Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.
Chung ES, Miller L, Patel AN, Anderson RD, Mendelsohn FO, Traverse J, Silver KH, Shin J, Ewald G, Farr MJ, Anwaruddin S, Plat F, Fisher SJ, AuWerter AT, Pastore JM, Aras R, Penn MS.
Eur Heart J; 2015 Sep 01; 36(33):2228-38. PubMed ID: 26056125
[Abstract] [Full Text] [Related]
16. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
[Abstract] [Full Text] [Related]
17. BNP-guided vs symptom-guided heart failure therapy: the Trial of Intensified vs Standard Medical Therapy in Elderly Patients With Congestive Heart Failure (TIME-CHF) randomized trial.
Pfisterer M, Buser P, Rickli H, Gutmann M, Erne P, Rickenbacher P, Vuillomenet A, Jeker U, Dubach P, Beer H, Yoon SI, Suter T, Osterhues HH, Schieber MM, Hilti P, Schindler R, Brunner-La Rocca HP, TIME-CHF Investigators.
JAMA; 2009 Jan 28; 301(4):383-92. PubMed ID: 19176440
[Abstract] [Full Text] [Related]
18. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
Hogenhuis J, Jaarsma T, Voors AA, Hillege HL, Lesman I, van Veldhuisen DJ.
Int J Cardiol; 2006 Mar 22; 108(1):63-7. PubMed ID: 16516699
[Abstract] [Full Text] [Related]
19. The effect of carvedilol on B-type natriuretic peptide and cardiac function in patients with heart failure and persistent atrial fibrillation.
Khand AU, Chew PG, Douglas H, Jones J, Jan A, Cleland JG.
Cardiology; 2015 Mar 22; 130(3):153-8. PubMed ID: 25660493
[Abstract] [Full Text] [Related]
20. The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure.
Lee SC, Stevens TL, Sandberg SM, Heublein DM, Nelson SM, Jougasaki M, Redfield MM, Burnett JC.
J Card Fail; 2002 Jun 22; 8(3):149-54. PubMed ID: 12140807
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
